Yes, Betaseron Treats Multiple Sclerosis
Betaseron (interferon beta-1b) is an FDA-approved injectable medication specifically for relapsing forms of multiple sclerosis (MS). It reduces the frequency of clinical exacerbations and delays progression of physical disability in adults with relapsing-remitting MS (RRMS), including patients who have experienced a first clinical episode with MRI features consistent with MS.[1]
How Betaseron Works for MS
Betaseron is a recombinant form of interferon beta, a protein that modulates the immune system. It decreases inflammation in the central nervous system, limits damage to myelin (the protective sheath around nerves), and reduces MS flare-ups by about one-third compared to placebo in clinical trials.[1][2]
Common Forms of MS It Targets
- Relapsing-remitting MS (RRMS): Primary use, slowing relapses and disability.
- Secondary-progressive MS (SPMS): Approved for active SPMS with relapses.
Not indicated for primary-progressive MS (PPMS).[1]
How It's Administered and Dosed
Subcutaneous injections of 0.25 mg every other day. Patients self-administer after training; a starter kit includes auto-injectors for ease.[1][3]
Side Effects Patients Report Most
Flu-like symptoms (fever, chills, muscle aches) hit 60-80% initially but often fade. Injection-site reactions, liver enzyme elevations, and depression occur; rare risks include severe allergic reactions or blood disorders. Monthly blood tests monitor liver function.[1][2]
How Betaseron Compares to Other MS Drugs
| Drug | Type | Dosing | Key Difference from Betaseron |
|------|------|--------|------------------------------|
| Avonex (interferon beta-1a) | Interferon | Weekly IM injection | Similar efficacy; less frequent dosing |
| Rebif (interferon beta-1a) | Interferon | 3x weekly SC | Higher relapse reduction in some trials |
| Tecfidera (dimethyl fumarate) | Oral | Twice daily | Fewer flu-like symptoms; higher infection risk |
| Ocrevus (ocrelizumab) | Monoclonal antibody | IV every 6 months | Stronger for progressive MS; infusion required |
All interferons like Betaseron show comparable moderate efficacy for RRMS but have more side effects than newer orals.[2][4]
Who Makes Betaseron and Generic Availability
Bayer HealthCare manufactures Betaseron. No FDA-approved generics exist due to its biologic nature (no small-molecule equivalent). Biosimilars are in development but face patent hurdles.1
When Does Betaseron's Patent Expire?
Core U.S. patents expired in the 2010s, but formulation and method-of-use patents extend protection. Check DrugPatentWatch.com for latest expiry dates and challenges—no generics approved as of 2023.5
[1]: FDA Label - Betaseron (accessdata.fda.gov/drugsatfda_docs/label/2021/103464s299lbl.pdf)
[2]: National MS Society - Interferon Beta Therapies (nationalmssociety.org)
[3]: Betaseron Prescribing Information (betaseron.com)
[4]: Cohen et al., NEJM 2010 (MS treatment comparisons)